Hépatite C : Soins nutritionnels - SOS hépatites

Bibliographie par chapitre71. Marotta PJ, Graziadei IW, Ghent CN : Muscle cramps : a 'complication' of cirrhosis. Can J Gastroenterol 2000; 14(SupplD):21D–25D72. Shoji S, Furuishi K, Misumi S et al : Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1)production. Biochem Biophys Res Commun 1994; 205(1):967–97573. Bonomi F, Pagani S : Uptake of iron by apoferritin from a ferric dihydrolipoate complex. Eur J Biochem 1991; 199(1):181–18674. Wallace AE, Weeks WB : Thiamine treatment of chronic hepatitis B infection. Am J Gastroenterol 2001; 96(3):864–86875. Levy S, Herve C, Delacoux E et al : Thiamine deficiency in hepatitis C virus and alcohol-related liver diseases. Dig Dis Sci 2002;47(3):543–54876. Rader JI, Calvert RJ, Hathcock JN : Hepatic toxicity of unmodified and time-release preparations of niacin. Am J Med 1992;92(1):77–8177. Garcia-Tevijano ER, Berasain C, Rodriguez JA et al : Hyperhomocysteinemia in liver cirrhosis : mechanisms and role in vascularand hepatic fibrosis. Hypertension 2001; 38(5):1217–122178. Habib A, Bacon BR, Ramrakhiani S : Hyperhomosteinemia in liver transplant recipients. [Abstract] Gastroenterology 2001;120(5): A56279. Herrero JI, Quiroga J, Sangro B et al : Hyperhomocysteinemia in liver transplant recipients : prevalence andmulti-variate analysis of predisposing factors. Liver Transpl 2000; 6(5):614–61880. Haque S, Chandra B, Gerber MA et al : Iron overload in patients with chronic hepatitis C : a clinicopathologic study. Hum Pathol1996; 27(12):1277–128181. Ioannou GN, Tung BY, Kowdley KV : Iron in hepatitis C : villain or innocent bystander? [Review] Semin Gastrointest Dis 2002;13(2):95–10882. Shedlofsky SI : Role of iron in the natural history and clinical course of hepatitis C disease. Hepato-Gastroent 1998;45(20):349–35583. Di Bisceglie AM, Bonkovsky HL, Chopra S et al : Iron reduction as an adjuvant to interferon therapy in patients with chronichepatitis C who have previously not responded to interferon : a multicenter, prospective, randomized, controlled trial. Hepatology2000; 32(1):135–13884. Guyader D, Boucher E, Andre P et al : A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients notresponding to interferon. Am J Gastroenterol 1999; 94(6):1696–169885. Herrera JL : Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed torespond to interferon therapy. Am J Gastroenterol 1999; 94(12):3571–357586. Hayashi H, Takikawa T, Nishimura N et al : Improvement of serum aminotransferase levels after phlebotomy in patients withchronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994; 89(7):986–98887. Beinker NK, Voight MD, Arendse M et al : Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitisB and C. J Hepatol 1996; 25(5):633–63888. Sartori M, Andorno S, La Terra G et al : Evaluation of iron status in patients with chronic hepatitis C. Ital J GastroenterolHepatol 1998; 30(4):402–40489. Bassett SE, Di Bisceglie AM, Bacon BR et al : Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.Hepatology 1999; 29(6):1884–189290. Angelucci E, Muretto P, Nicolucci A et al : Effects of iron overload and hepatitis C virus positivity in determining progression ofliver fibrosis in thalassemia following bone marrow transplantation. Blood 2002; 100(1):17–2191. Fargion S, Fracanzani AL, Rossini A et al : Iron reduction and sustained response to interferon-alpha therapy in patients withchronic hepatitis C : results of an Italian multicenter randomized study. Am J Gastroenterol 2002; 97(5):1204–121092. Tsai NC, Zuckerman E, Han SH et al : Effect of iron depletion on long-term response to interferon-alpha in patients with chronichepatitis C who previously did not respond to interferon therapy. Am J Gastroenterol 1997; 92(10):1831–183493. Pianko S, McHutchison JG, Gordon SC et al : Hepatic iron concentration does not influence response to therapy with interferonplus ribavirin in chronic HCV infection. J Interferon Cytokine Res 2002; 22(4):483–48994. Distante S, Bjoro K, Hellum KB et al : Raised serum ferritin predicts non-response to interferon and ribavirin treatment inpatients with chronic hepatitis C infection. Liver 2002; 22(3):269–27595. Kato J, Kobune M, Nakamura T et al : Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitisC patients by phlebotomy and low iron diet. Cancer Res 2001; 61(24):8697–870296. Tandon N, Thakur V, Guptan RK et al : Beneficial influence of an indigenous low-iron diet on serum indicators of iron status inpatients with chronic liver disease. Br J Nutr 2000; 83(3):235–23997. Isawa M, Kaito M, Ikoma J et al : Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.Hepatogastroenterology 2002; 49(44):529–53198. Hourigan LF, Macdonald GA, Purdie D et al : Fibrosis in chronic hepatitis C correlates significantly with body mass index andsteatosis. Hepatology 1999; 29(4):1215–121999. Baum MK, Miguez-Burbano MJ, Campa A et al : Selenium and interleukins in persons infected with human immunodeficiencyvirus type 1. J Infect Dis 2000; 182(Suppl 1):S69–S73100. Takagi H, Nagamine T, Abe T et al : Zinc supplementation enhances the response to interferon therapy in patients with chronichepatitis C. J Viral Hepat 2001; 8(5):367–371101. Marchesini G, Fabbri A, Bianchi G et al : Zinc supplementation and amino acid-nitrogen metabolism in patients with advancedcirrhosis. Hepatology 1996; 23(5):1084–1092102. Kugelmas M : Preliminary observation : oral zinc sulfate replacement is effective in treating muscle cramps in cirrhoticpatients. J Am Coll Nutr 2000; 19(1):13–15Hépatite C : Soins nutritionnelsLignes directrices canadiennes pour les intervenants de la santé51